ZVRA Zevra Therapeutics, Inc.

$12.87 +2.26%

Healthcare · Pharmaceutical Preparations

Zevra Therapeutics, Inc. (ZVRA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $761 million. Shares last traded at $12.87, 9.7% below their 52-week high. Over the past year the stock is up 45.8%. ZVRA trades at a price-to-earnings ratio of 9.14, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 78.2%, above the peer median of -0.1%. Revenue grew 350.9% year over year.

Market Cap

$761M

Shares Out

59.1M

EPS (TTM)

$2.86

P/E Ratio

4.50

P/S Ratio

7.15

P/B Ratio

3.70

Dividend / Share

—

Dividend Yield

—

52-Week High

$14.26

52-Week Low

$7.16

Volume

73,930

Avg Vol (3m)

72,797.984

Performance

-0.77%

+26.30%

+36.91%

+58.40%

YTD

+54.22%

+45.75%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

61.42

SMA (50)

$10.95

SMA (200)

$9.60

Price vs SMA50

+17.51%

Price vs SMA200

+34.05%

ATR (14)

$0.71

Financials

Revenue

$106M

Net Income

$83M

Gross Margin

—

Operating Margin

-59.1%

Net Margin

78.2%

Return on Equity

40.4%

Return on Assets

29.9%

Current Ratio

4.89

Debt / Equity

0.00

Revenue Growth (YoY)

+350.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.60	2026-05-06
FY 2025	$1.35	2026-03-09
Q3 2025	$1.16	2025-11-05
Q2 2025	$1.16	2025-08-12
Q1 2026	$-0.06	2026-05-06
FY 2025	$-2.28	2026-03-09

Full earnings history →

Pharmaceutical Preparations peers

ZVRA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

9.14 / 16.82 med

-46% discount

P/S vs peers

7.15 / 3.54 med

+102% premium

Net margin vs peers

78.2% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.